Warrier Rajasekharan, Chauhan Aman
Department of Pediatric Hematology and Oncology, Ochsner Clinic Foundation, New Orleans, LA.
Ochsner J. 2012 Fall;12(3):221-7.
Rapid strides have been made in the field of hematology, and advances in immune thrombocytopenic purpura (ITP) management are no exception. From idiopathic to immune, the changed nomenclature is itself a testimonial to the growing awareness and improvements in the management of ITP. We discuss the pathophysiology, clinical presentation, and current management of this common pediatric disorder and summarize current guidelines for ITP treatment.
血液学领域已取得长足进步,免疫性血小板减少性紫癜(ITP)管理方面的进展也不例外。从特发性到免疫性,名称的改变本身就证明了对ITP管理的认识不断提高和管理方法的改进。我们讨论这种常见儿科疾病的病理生理学、临床表现和当前管理方法,并总结ITP治疗的当前指南。